Thane Wettig - Aug 7, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Commercial Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Aug 7, 2023
Transactions value $
$0
Form type
4
Date filed
8/9/2023, 05:28 PM
Previous filing
Jun 26, 2023
Next filing
Sep 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Award $0 +200K +184.74% $0.00 308K Aug 7, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +300K $0.00 300K Aug 7, 2023 Common Stock 300K $1.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of Restricted Stock Units ("RSUs") that vest quarterly over 1 year from August 1, 2023, subject to the reporting person's continued service with the company on each such date.
F2 Twenty-Five percent of the shares subject to the option vest on August 7, 2024 and the remainder vest quarterly in equal installments over the following 3 years, subject to the reporting person's continued service with the company on each such date.